NSC identifier: |
NSC 694269
|
Compound name: |
Benzimidazo[1,2-a][1,8]naphthyridin-7-ium, 6-cyano-5-[[2-(3-methoxyphenyl)ethyl]amino]- 7-methyl-, 4-methylbenzenesulfonate |
CRmiRSNP:
~ Export ~
|
Records:16
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
NSC 694269 |
rs724710 |
4.27E-05 |
M4 |
BCL2L11 |
0.028 |
Target_3'utr |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:2 Current:2
First Prev [Next] [Last] 
|
SNP:
~ Export ~
|
Records:null
Compound |
SNP |
Significance |
OR value |
Model |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:35
Expression pattern: Sensitivity / Resistance
Total:3 Current:1
[First] [Prev]  Next Last 
|
Gene:
~ Export ~
|
Records:3363
Compound |
Gene |
Significance |
Expression pattern |
NSC 694269 |
CDSN |
0.001 |
Down Regulated |
NSC 694269 |
CDX1 |
0.001 |
Down Regulated |
NSC 694269 |
CDX2 |
0.001 |
Down Regulated |
NSC 694269 |
CEBPA |
0.001 |
Down Regulated |
NSC 694269 |
CHAD |
0.001 |
Down Regulated |
NSC 694269 |
RCC1 |
0.001 |
Down Regulated |
NSC 694269 |
CHIT1 |
0.001 |
Down Regulated |
NSC 694269 |
CLCNKA |
0.001 |
Down Regulated |
NSC 694269 |
CLPS |
0.001 |
Down Regulated |
NSC 694269 |
CCR4 |
0.001 |
Down Regulated |
NSC 694269 |
CLDN7 |
0.001 |
Down Regulated |
NSC 694269 |
CRX |
0.001 |
Down Regulated |
NSC 694269 |
CSF1R |
0.001 |
Down Regulated |
NSC 694269 |
CTSL1 |
0.001 |
Up Regulated |
NSC 694269 |
CYP2A7 |
0.001 |
Down Regulated |
Expression pattern: Sensitivity / Resistance
Total:225 Current:1
[First] [Prev]  Next Last 
|